A Study of the Effect of Combination Lumacaftor and Ivacaftor on Markers of Hyperglycemia in Persons With Cystic Fibrosis
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Ivacaftor/lumacaftor (Primary)
- Indications Cystic fibrosis
- Focus Pharmacodynamics
- 17 May 2018 Status changed from not yet recruiting to discontinued.
- 09 Aug 2016 New trial record